References - Therapeutic Strategies in Cancer Biology and Pathology - page 233

Minn, A.H., Hafele, C., Shalev, A., 2005. Thioredoxin-interacting protein is stimulated by
glucose through a carbohydrate response element and induces beta-cell apoptosis.
Endocrinology 146, 2397-2405.
Minor, J., Wang, X., Zhang, F., Song, J., Jimeno, A., et al., 2012. Methylation of microRNA-9
is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcino-
mas. Oral Oncol. 48, 73-78.
Misawa, A., Katayama, R., Koike, S., Tomida, A., Watanabe, T., Fujita, N., 2010. AP-1-
dependent miR-21 expression contributes to chemoresistance in cancer stem cell-like SP
cells. Oncol. Res. 19, 23-33.
Mischke, D., Korge, B.P., Marenholz, I., Volz, A., Ziegler, A., 1996. Genes encoding struc-
tural proteins of epidermal cornification and S100 calcium-binding proteins form a gene
complex (“epidermal differentiation complex”) on human chromosome 1q21. J. Invest.
Dermatol. 106, 989-992.
Mishra, M., Karagiannis, J., Sevugan, M., Singh, P., Balasubramanian, M.K., 2005. The
14-3-3 protein Rad24p modulates function of the Cdcl4p family phosphatase Clp1p/
Flp1p in fission yeast. Curr. Biol. 15, 1376-1383.
Mitchell, D.C., Stafford, L.J., Li, D., Bar-Eli, M., Liu, M., 2007. Transcriptional regulation of
KiSS-1 gene expression in metastatic melanoma by specificity protein-1 and its coactiva-
tor DRIP-130. Oncogene 26, 1739-1747.
Mizuno, Y., Tokuzawa, Y., Ninomiya Y., Yagi K, Yatsuka-Kanesaki Y., Suda, T., et al. (2009).
miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett.,
583(13), 2263-2268.
Moggs, J.G., Grandi, P., Quivy, J.P., Jónsson, Z.O., Hübscher, U., Becker, P.B., et al., 2000. A
CAF-1-PCNA-mediated chromatin assembly pathway triggered by sensing DNA dam-
age. Mol. Cell Biol. 20, 1206-2018.
Mohsin, S.K., Zhang, M., Clark, G.M., Allred, D.C., 2003. Maspin expression in invasive
breast cancer: association with other prognostic factors. J. Pathol. 199, 432-435.
Moreira, J.M.A., Ohlsson, G., Rank, F.E., Celis, J.E., 2005. Down-regulation of the tumor
suppressor protein 14-3-3 sigma is a sporadic event in cancer of the breast. Mol. Cell
Proteomics 4, 555-569.
Moreno, A., Palacios, A., Orgaz, J.L., Jimenez, B., Blanco, F.J., Palmero, I., 2010. Functional
impact of cancer-associated mutations in the tumor suppressor protein ING4.
Carcinogenesis 31, 1932-1938.
Morgenstern, B., Atchley, W.R. 1999. Evolution of bHLH transcription factors: Modular evo-
lution by domain shuffling? Mol. Biol. Evolution 16, 1654-1663.
Moriyama-Kita, M., Endo, Y., Yonemura, Y., Heizmann, C.W., Miyamori, H., Sato, H., et al.,
2005. S100A4 regulates E-cadherin expression in oral squamous cell carcinoma. Cancer
Lett. 230, 211-218.
Morrow, K.A., Das, S., Metge, B.J., Ye, K., Mulekar, M.S., Tucker, J.A., et al., 2011. Loss of
tumor suppressor Merlin in advanced breast cancer is due to post-translational regulation.
J. Biol. Chem 286, 40376-40385.
Morton, J.P., Jamieson, N.B., Karim, S.A., Athineos, D., Ridgway, R.A., Nixon, C., et al.,
2010. LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer
through suppression of p21-dependent growth arrest. Gastroenterology 139, 586-597.
Moskwa, P., Buffa, F.M., Pan, Y., Panchakshari, R., Gottipati, P., Muschel, R.J., et al., 2011.
miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to
PARP inhibitors. Mol. Cell 41, 210-220.
Mueller, M.T., Hermann, P.C., Witthauer, J., Rubio-Viqueira, B., Leicht, S.F., Huber, S., et al.,
2009. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human
pancreatic cancer. Gastroenterology 137, 1102-1113.